Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Capital Employed (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Return on Capital Employed data on record, last reported at 0.48% in Q1 2025.

  • For Q1 2025, Return on Capital Employed changed N/A year-over-year to 0.48%; the TTM value through Mar 2025 reached 0.48%, changed N/A, while the annual FY2024 figure was 0.49%, 21.0% up from the prior year.
  • Return on Capital Employed reached 0.48% in Q1 2025 per ARQT's latest filing, down from 0.41% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.41% in Q4 2024 and bottomed at 1.01% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.67%, with a median of 0.66% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: fell -21bps in 2023, then surged 48bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.57% in 2021, then fell by -21bps to 0.68% in 2022, then plummeted by -30bps to 0.89% in 2023, then skyrocketed by 54bps to 0.41% in 2024, then dropped by -15bps to 0.48% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.48% in Q1 2025, 0.41% in Q4 2024, and 0.89% in Q4 2023.